+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2019-2023 - Product Image

Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2019-2023

  • ID: 4792949
  • Report
  • June 2019
  • Region: Global
  • 130 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN Group
  • MORE

Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market: About this market:

Human immunodeficiency virus rapid test kits are used for the detection of HIV antibodies present in the body. The HIV rapid tests provide results in few minutes, thereby eliminating the need for longer waiting period. This human immunodeficiency virus rapid test kits market analysis considers the revenue generation based on end-users that includes diagnostic centers, and hospitals and clinics. Our analysis also considers the sales of human immunodeficiency virus rapid test kits in North America, Europe, Asia, and RoW. In 2018, the diagnostic centers segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing awareness about the benefits of early detection play a significant role in the diagnostic centers segment to maintain their market position. Also, our global human immunodeficiency virus rapid test kits market report looks at factors such as the rise in awareness programs for HIV testing, growing demand for point-of-care testing for HIV, and the high prevalence of HIV. However, the non-availability of rapid HIV products in limited resource settings, limited healthcare services in developing regions, and lack of trained professionals may hamper the growth of the human immunodeficiency virus rapid test kits industry over the forecast period.

Global human immunodeficiency virus rapid test kits market: Overview

Growing demand for point-of-care testing for HIV

The demand for point-of-care testing for HIV is increasing at a significant rate as POC testing technologies are affordable and easily accessible. Point-of-care testing can also detect HIV at an early stage, which is essential to start primary treatment and prevent the onset of AIDS. Thus, the growing demand for point-of-care testing for HIV will fuel the growth of the HIV test kits market at a CAGR of more than 7% during the forecast period.

Availability of a broad range of HIV rapid test kits by vendors

Vendors in the market are increasingly focusing on manufacturing innovative test kits to cater to the growing demand for HIV testing. The demand is increasing mainly driven by a paradigm shift from treatment to the preventive healthcare system. Thus, the availability of a broad range of HIV rapid test kits by vendors is identified as a key HIV test kits market trends that will fuel the growth of the market during the forecast period.

Competitive Landscape

With the presence of few major players, the global human immunodeficiency virus rapid test kits market is moderately concentrated. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading HIV test kits manufacturers, that include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., and QIAGEN Group.

Also, the human immunodeficiency virus rapid test kits market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN Group
  • MORE

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Diagnostic centers - Market size and forecast 2018-2023
  • Hospitals and clinics - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY TYPE

  • HIV rapid immunoassay test
  • HIV rapid molecular diagnostic test

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • RoW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Efforts to increase pre-marital screenings for HIV
  • Increasing clinical studies by researchers and promotional activities by manufacturers
  • Availability of a broad range of HIV rapid test kits by vendors

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN Group

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 16: EXPLORE

List of Exhibits
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: End-user - Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Diagnostic centers - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Diagnostic centers - Year-over-year growth 2019-2023 (%)
Exhibit 21: Hospitals and clinics - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Hospitals and clinics - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by end-user
Exhibit 24: Customer landscape
Exhibit 25: Market share of global human immunodeficiency virus (HIV) rapid test kits market by test type 2018
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Abbott Laboratories - Vendor overview
Exhibit 45: Abbott Laboratories - Business segments
Exhibit 46: Abbott Laboratories - Organizational developments
Exhibit 47: Abbott Laboratories - Geographic focus
Exhibit 48: Abbott Laboratories - Segment focus
Exhibit 49: Abbott Laboratories - Key offerings
Exhibit 50: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 51: Bio-Rad Laboratories Inc. - Business segments
Exhibit 52: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 53: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 54: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 55: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 56: Danaher Corp. - Vendor overview
Exhibit 57: Danaher Corp. - Business segments
Exhibit 58: Danaher Corp. - Organizational developments
Exhibit 59: Danaher Corp. - Geographic focus
Exhibit 60: Danaher Corp. - Segment focus
Exhibit 61: Danaher Corp. - Key offerings
Exhibit 62: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 63: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 64: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 65: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 66: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 67: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 68: QIAGEN Group - Vendor overview
Exhibit 69: QIAGEN Group - Product segments
Exhibit 70: QIAGEN Group - Organizational developments
Exhibit 71: QIAGEN Group - Geographic focus
Exhibit 72: QIAGEN Group - Segment focus
Exhibit 73: QIAGEN Group - Key offerings
Exhibit 74: Validation techniques employed for market sizing
Exhibit 75: Definition of market positioning of vendors

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN Group
  • MORE
The following companies are recognised as the key players in the global human immunodeficiency virus rapid test kits market: Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., and QIAGEN Group.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the availability of a broad range of HIV rapid test kits by vendors.”

According to the report, one of the major drivers for this market is the growing demand for point-of-care testing for HIV.

Further, the report states that one of the major factors hindering the growth of this market is the limited healthcare services in developing regions.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN Group
Note: Product cover images may vary from those shown
Adroll
adroll